Royalty Pharma plcRPRXNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank60
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P60
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202520.66%
2024-13.38%
2023385.94%
2022-78.54%
2021-10.32%
2020-39.18%
201992.25%
201845.20%
201729.99%
2016-8.99%